| Stage | DY | % of rev | MTZ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.0B | 100.00% | $5.2B | 100.00% | MTZ ×2.57 |
| Gross profit | $441M | 21.96% | $661M | 12.83% | DY +9.1pp |
| Operating income | $192M | 9.57% | $275M | 5.35% | DY +4.2pp |
| Pre-tax income | $154M | 7.68% | $220M | 4.27% | DY +3.4pp |
| Net income | $116M | 5.76% | $168M | 3.26% | DY +2.5pp |
| Stage | DY | MTZ | Gap · A − B |
|---|---|---|---|
| Revenue | $2.0B100.00% | $5.2B100.00% | MTZ ×2.57 |
| Gross profit | 21.96%$441M | 12.83%$661M | DY +9.1pp |
| Operating income | 9.57%$192M | 5.35%$275M | DY +4.2pp |
| Pre-tax income | 7.68%$154M | 4.27%$220M | DY +3.4pp |
| Net income |
| 5.76%$116M |
| 3.26%$168M |
| DY +2.5pp |
No disclosed counterparties: MTZ.
None